参考文献 References
[1] Sun, H., Y. Song and X. Wang, Effects of Different Anesthetic Methods on Cellular Immune and Neuroendocrine Functions in Patients With Hepatocellular Carcinoma Before and After Surgery. Journal of clinical laboratory analysis, 2016. 30(6).
[2] Beloribi-Djefaflia, S., S. Vasseur and F. Guillaumond, Lipid metabolic reprogramming in cancer cells. Oncogene-sis, 2016. 5(1).
[3] 陈诗芮等, CircRNA调控脂质代谢对相关疾病进展的影响. 生命的化学, 2022. 42(09): 第1685-1693页.
[4] 王玉敏等, MicroRNAs靶向脂代谢重编程参与肝细胞癌发生的研究进展. 基础医学与临床, 2022. 42(12): 第1930-1934页.
[5] Peck, B. and A. Schulze, Lipid desaturation - the next step in targeting lipogenesis in cancer? The FEBS journal, 2016. 283(15).
[6] Zuzanna, T. and D. Pawel, Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer. Cancers, 2019. 11(7).
[7] Li, Q., et al., circPRKAA1 activates a Ku80/Ku70/SREBP-1 axis driving de novo fatty acid synthesis in cancer cells. Cell Reports, 2022. 41(8).
[8] Yan, S., et al., Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update. World journal of gastroenterology, 2015. 21(12).
[9] Guo, X., et al., Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis. BioMed research international, 2017. 2017.
[10] Yang, W., et al., Hsa_circ_0048179 attenuates free fatty acid-induced steatosis via hsa_circ_0048179/miR-188-3p/GPX4 signaling. Aging, 2020. 12(23).
[11] Li, J., et al., A nanodrug system overexpressed circRNA
_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis. Journal of Nanobiotechnology, 2021. 19(1).
[12] Xing-Ya, G., et al., circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling. World Journal of Gastroenterology, 2018. 24(03): p. 323-337.
[13] Xing-Ya, G., et al., circRNA_0046367 Prevents Hepatoxi-city of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis. Oxidative Medicine and Cellular Longevity, 2017. 2017.
[14] Stefano, V., Intracellular Lipid Droplets: From Structure to Function. Lipid Insights, 2017. 10.
[15] Shiro, K. and M. Yohei, Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia. IJMS, 2016. 17(9).
[16] Jeremy, E.W. and A.S. Phillip, A Circuitous Route to Noncoding RNA. Science, 2013. 340(6131).
[17] Jin, X., et al., Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy. Cell death & disease, 2020. 11(2).
[18] Chen, X., et al., Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206. Cell Death & Disease, 2021. 12(9).
[19] Li, P., et al., CircScd1 Promotes Fatty Liver Disease via the Janus Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway. Digestive diseases and sciences, 2019. 64(1).
[20] Li, J., et al., A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis. Journal of Nanobiotechnology, 2021. 19(1).